Lessening Organ Dysfunction With VITamin C - COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

July 15, 2022

Study Completion Date

December 6, 2022

Conditions
Vitamin CCOVID-19Hospitalized Patients
Interventions
DRUG

Vitamin C

Intravenous vitamin C administered in bolus doses of 50 mg/kg mixed in a 50-ml solution of either normal saline (0.9% NaCl) or dextrose 5% in water (D5W) during 30 to 60 minutes, every 6 hours for 96 hours (i.e. 200 mg/kg/day and 16 doses in total).

DRUG

Control

Dextrose 5% in water of normal saline (0.9% NaCL) in a volume to match vitamin C.

Trial Locations (2)

J1H 5N4

Research Center of the CHUS, Sherbrooke

Research Centre of the CHUS, Sherbrooke

All Listed Sponsors
collaborator

Lotte & John Hecht Memorial Foundation

OTHER

lead

Université de Sherbrooke

OTHER

NCT04401150 - Lessening Organ Dysfunction With VITamin C - COVID-19 | Biotech Hunter | Biotech Hunter